Symbol="EDSA"
AssetType="Common Stock"
Name="Edesa Biotech Inc"
Description="Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development, manufacture and marketing of pharmaceuticals for inflammatory and immune-related diseases. The company is headquartered in Markham, Canada."
CIK="1540159"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="332 EAST SCOTT STREET, PORT HUENEME, CA, US"
FiscalYearEnd="September"
LatestQuarter="2023-06-30"
MarketCapitalization="17913400"
EBITDA="-9532970"
PERatio="None"
PEGRatio="None"
BookValue="0.376"
DividendPerShare="0"
DividendYield="0"
EPS="-0.61"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.449"
ReturnOnEquityTTM="-0.962"
RevenueTTM="500"
GrossProfitTTM="311200"
DilutedEPSTTM="-0.61"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.999"
AnalystTargetPrice="8.33"
TrailingPE="-"
ForwardPE="0.172"
PriceToSalesRatioTTM="120477.93"
PriceToBookRatio="1.422"
EVToRevenue="128525.38"
EVToEBITDA="-0.223"
Beta="0.747"
num_52WeekHigh="2.81"
num_52WeekLow="0.76"
num_50DayMovingAverage="0.843"
num_200DayMovingAverage="1.127"
SharesOutstanding="20587700"
DividendDate="2019-06-10"
ExDividendDate="None"
symbol="EDSA"
open="0.86"
high="0.89"
low="0.85"
price="0.87"
volume="12870.00"
latest_trading_day="2023-08-18"
previous_close="0.85"
change="0.02"
change_percent="2.3647%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="66847"
Change_recent_avg="0.01"
Delta_recent_avg="0.06"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-0.5"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="97"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0079.jpeg"
image_negative_thumbnail_id_2="140"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0036.jpeg"
image_neutral_thumbnail_id_1="535"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0064.jpeg"
image_neutral_thumbnail_id_2="529"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_positive_thumbnail_id_1="1002"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0164.jpeg"
image_positive_thumbnail_id_2="636"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0072.jpeg"
image_professor_thumbnail_id_1="1176"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
